Thomas Chi

PainRelief.com Interview with: Nathaniel M. Schuster, MDPain and Headache NeurologistAssociate ProfessorCenter for Pain MedicineDepartment of AnesthesiologyUC San Diego Health Schuster, Nathaniel, MD, Pain Medecine PainRelief.com: What is the background for this study? Response: Many Americans self-treat migraine with cannabis. #@UCSDHealth ##AANAM ##cannabis ##neurology ##painrelief

2

Discover expert faculty perspectives on recurrent/metastatic #HNSCC in this must-attend #CME #NCPD activity. 🌟 Glenn J. Hanna, MD, Director of the Center for Cancer Therapeutic Innovation at Dana-Farber Cancer Institute, and Deborah Wong, MD, PhD, Associate Clinical Professor of Medicine at UCLA Medical Center, will share: 🔬 Case studies of patients with recurrent/metastatic HNSCC 📊 Insights on the latest efficacy and safety data 🛡️ Strategies to prevent and mitigate immune-mediated adverse events 🤝 The importance of an interprofessional approach to surveillance and survivorship #Oncology #MedicalEducation #CancerTreatment #HealthcareProfessionals #CE #Physician #Nurse #OncologyNursing #HeadAndNeckOncology

1

Akito Hata, MD is oncologist at Kobe Minimally Invasive Cancer Medical Center Department of Thoracic Oncology, Japan peresetns their submitted abstract on American Society of Clinical Oncology (ASCO) 24. New study on a PDL-1 positive lung cancer treatment that uses chemotherapy and immunotherapy, eliminating the need for radiation #cancerresearch #lungcancer #lungcancerawareness #oncodailyasco24update #asco24updates #immunotherapy #radiotherapy #oncology

27

The rise in lung cancer rates among female non-smokers might be linked to radon inhalation. This theory is based on the differences in radon exposure between males and females, which can be attributed to the variations in time spent indoors versus outdoors.  Source: Safari, A., et al. (2024). "Exploring the Disparity in Indoor/Outdoor Time and Radon Exposure as Possible Factors Contributing to the Unexpected Increase in Lung Cancer Risk among Non-Smoking Women." Journal of Biomedical Physics and Engineering. in press. https://lnkd.in/ewvumYy9 #lung #cancer #females #nonsmokers #radon #Indoor #Outdoor

16

1 Comment

#InTheNews: After presenting new data from our Phase 2a #clinicaltrial of ENV-101, investigator Toby Maher, M.D., Ph.D., Professor of Medicine and Director of Interstitial Lung Disease at Keck School of Medicine of the University of Southern California discussed the findings with Healio.    In this article, hear Dr. Maher’s perspective on the tremendous need for idiopathic pulmonary fibrosis (#IPF) treatments that do more than slow the decline of lung function and why #pulmonologists are keeping a close eye on Endeavor’s ENV-101: https://bit.ly/3VrSNvr    #biotechnews #science #lungdisease 

95

2 Comments

Who could imagine that a targeted drug designed for ovarian cancer could put infants and toddlers with a rare, poor prognosis #leukemia (AML) into remission? Continued thanks to Sutro Biopharma, Inc. and their CEO Bill Newell for truly listening to pediatric researcher Soheil Meshinchi MD., Ph.D. when he discovered a new therapeutic target and #drugrepurposing opportunity. After much deliberation, Sutro bravely decided to offer this drug on COMPASSIONATE USE with remarkable results. Numerous children have benefitted from their drug, plus we may have identified/solved a piece of the #precisionmedicine puzzle in childhood AML, a diverse and complex #raredisease. I encourage all #pharma companies to consider offering promising, especially TARGETED agents on compassionate use/expanded access to kids with no remaining treatment options. As it stands, kids must wait an average of 6.5 years longer than adults to trial new #cancer drugs. As many as 40% will respond to targeted agents offered on compassionate use if their cancer expresses that target. Look at the history of cancer. From the book, Emperor of all Maladies: many of the biggest breakthroughs in cancer were pioneered by children. And yet, in modern times, kids are often pushed to the back of the line to try & trial new drugs. As part of your company's #DEI initiatives, please consider prioritizing & INCLUDING kids & teens with cancer by offering compassionate use/expanded access and pushing relevant adult #clinicaltrials down to age 12 (per FDA guidance). Thanks again to Sutro, Dr. Meshinchi, and the many families and foundations who collaborated to fund the target discovery & preclinical work that enabled this finding --- pooling money to fund mission-critical work that just didn't fit within traditional grant mechanisms! #ProjectStella #TargetPediatricAML #FredHutch #collaboration

63

4 Comments

Join us on June 12 when Dr. Fei Wang from Cornell University presents on "Disentangling the clinical complexity of heterogeneous diseases through data-driven subphenotyping with large scale electronic health records." To register, click here: https://lnkd.in/dYYgQEXz

5

How is precision medicine revolutionizing health care? 🧬 Kaiser Permanente is leading the way with personalized care through precision medicine and genomics.  Dinesh Kotak, MD, explains how we're creating customized treatment plans based on unique lifestyle, environment, and DNA factors. Discover how this approach is transforming prevention, diagnosis, and treatment.  Read more: https://lnkd.in/gSJckBXy  #PrecisionMedicine #PermanenteMedicine #HealthcareInnovation #Genomics #KaiserPermanente 

26

Thinking about breast augmentation? 🌟 Discover everything you need to know in my latest blog, 'Understanding Breast Augmentation in Alameda.' Get the facts, tips, and expert advice to make an informed decision. Don't miss out! 📖 Read the full blog here: https://loom.ly/ypPMdqY #BreastAugmentation #AlamedaBeauty #CosmeticSurgery #ExpertAdvice #BeautyTips

1

🧑‍🏫 Maidah Yaqoob, MD, Assistant Professor of Medicine, Department of Pulmonary and Critical Care, walks through how the PERT at Cedars-Sinai risk stratifies pulmonary embolisms and how AI helps facilitate closer collaboration between medical disciplines in patient care. #healthcareai #aiinhealthcare #vascular

22

1 Comment

Dr. Anna Chen Arroyo, MD, MPH, a faculty member at Stanford CARE, has recently published a new study titled “Asian American Patients With Allergic Diseases: Considerations for Research and Clinical Care” in the Journal of Allergy and Clinical Immunology. The study examines how characterizing allergies and understanding the sociocultural dimensions of care for Asian American patients with allergies may better their health outcomes. The study outlines the need for further research on allergic diseases among Asian American patients as it is crucial to understand unique environmental risk factors, especially considering how nativity and acculturation may affect these risks. It states that while some differences in allergic diseases between Asian and American populations exist, data from Asia may not be directly applicable to Asian Americans due to environmental and dietary variations. Understanding the sociocultural context of Asian American patients is vital for improving clinical management, considering factors such as language barriers, cultural expectations, and socioeconomic disparities, and necessitates allergists to avoid making assumptions and address individual patient needs within their cultural frameworks. To read more about it, please visit: https://lnkd.in/g2sDYBvM To learn more about the research that CARE is spearheading, make sure to visit Stanford CARE at Asianhealth.stanford.edu #Asianamericanhealth #asianhealth #stanford #medicine #allergies #spring #healthdisparities #healthequity #healthcaresolutions #research #education

12

Bridging one of the biggest gaps in the healthcare system: equal access to treatment, especially in minority populations 🌎 A study conducted across two cancer centers – Penn Medicine���s Abramson Cancer Center and Oregon Health & Science University’s Knight Cancer Institute – found that while local community cancer care access was equitable, broader disparities still exist. By assessing the percentage of patients from minority health populations treated at each cancer center between 2018 and 2022, the study discovered CAR-T cell therapy was limited for these patients. While the study did not aim to determine the cause of these inequities, researchers theorize that contributing factors could include clinical barriers, provider barriers, and socioeconomic barriers. Improving patient access, healthcare policies and inclusive clinical trials will help to ensure that patients from all socio-economic and ethnic backgrounds can benefit from life-changing treatment. Read more via University of Pennsylvania ➡️ https://lnkd.in/epgdt83U #ManufacturingBrighterFutures #CellTherapy #GeneTherapy #PatientAccess #Biotechnology

25

Save the date for our upcoming Integrative Medicine Research Lecture: Harnessing AI To Explore Health Restoration in Diabetes. On July 29, Dr. Aaron Lee of the University of Washington, recognized as a leader in the field of AI and ophthalmology, will discuss a project he’s leading to develop multimodal, high-quality, ethically sourced data that will be ready for AI/machine learning methods to study salutogenesis in the context of type 2 diabetes. Learn more here: https://go.nih.gov/p5Jm8UK     

4

Wendy Diller, MedTech Strategist Senior Writer/Market Analyst, asks Stephen Kingsmore, president and CEO of Rady Children's Institute for Genomic Medicine in San Diego: What is the clinical utility of these Project Baby Bear tests? When I think of treatments for rare diseases, I think of advances that we have had in things like gene therapy, etc. But I think you're talking about some more basic therapies as well (see Figure 1 below). Stephen Kingsmore: The unknown thing about this field that staggers people is that treatments for many of these diseases are changes in diet, either supplements or avoidance of something you cannot metabolize. For example, all it takes for a newborn with phenylketonuria [PKU] is to stay away from phenylalanine and have a phenylalanine-free diet. You don't need a drug. For others, it's a pill. For others, it's surgical intervention. If you have a bone marrow failure syndrome, you need a bone marrow transplant; if you have something that's going to give you a cardiomyopathy, you're going to need a new heart. And then devices would be the last class. So, all four types of interventions. As advances in gene and cell therapies make the possibility of curing some inherited genetic diseases a reality, the need for rapid screening and diagnosis of genetic variants is getting more urgent. Immunologist and cell therapy expert Stephen Kingsmore is at the forefront of making that happen: https://bit.ly/3xYpYh3 Source of image: A Genome Sequencing System for Universal Newborn Screening, Diagnosis, and Precision Medicine for Severe Genetic Diseases. "The American Journal of Human Genetics," 109, 1605-1619, September 1, 2022. #medtech #medicaldevices #celltherapy #geneticdisease #bonemarrowtransplant #ProjectBabyBear

1

1 Comment

⚠️ Following cervical and uterine cancer, #ovariancancer (OC) ranks third in gynecologic cancers for frequency but has the highest rate of death. OC often remains non-diagnosed until it spreads throughout the pelvis and abdomen, making treatment difficult. 🔬 For this reason, prevention and early diagnosis are essential. We are proud to have contributed to the creation of AZFastNet, a platform developed with the goal of simplifying access to molecular diagnostic tests in the field of oncology and oncohematology. 🖥️ Thanks to this application, Italian oncology centers can connect with highly qualified molecular diagnostic laboratories, allowing clinicians from all authorized healthcare facilities for the treatment of ovarian and/or lung carcinoma to easily and directly request the execution of tests for determining the mutational status of the BRCA1/BRCA2 and EGFR genes. ➡️ Discover more: https://lnkd.in/deyNKzGb World Ovarian Cancer Coalition | #OvarianCancerDay #worldovariancancerday #womenhealth #digitalhealth #medtech #AIhealth | AstraZeneca

9

Interesting study to improve colon cancer screening rates !

4